Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Intangibles (2016 - 2025)

Standard Biotools (LAB) has disclosed Intangibles for 11 consecutive years, with $29.0 million as the latest value for Q4 2024.

  • On a quarterly basis, Intangibles rose 1968.14% to $29.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $29.0 million, a 1968.14% increase, with the full-year FY2024 number at $29.0 million, up 1968.14% from a year prior.
  • Intangibles was $29.0 million for Q4 2024 at Standard Biotools, up from $23.4 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $40.2 million in Q4 2020 to a low of $1.4 million in Q4 2023.
  • A 5-year average of $21.1 million and a median of $25.6 million in 2021 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: plummeted 88.89% in 2023, then soared 1968.14% in 2024.
  • Standard Biotools' Intangibles stood at $40.2 million in 2020, then plummeted by 30.54% to $27.9 million in 2021, then tumbled by 54.88% to $12.6 million in 2022, then tumbled by 88.89% to $1.4 million in 2023, then skyrocketed by 1968.14% to $29.0 million in 2024.
  • Per Business Quant, the three most recent readings for LAB's Intangibles are $29.0 million (Q4 2024), $23.4 million (Q3 2024), and $1.4 million (Q4 2023).